Comparison of <font color="blue">weakness_1</font> <font color="blue">progression_1</font> <font color="blue">in_1</font> <font color="blue">inclusion_2</font> <font color="blue">body_2</font> <font color="blue">myositis_2</font> <font color="blue">during_1</font> <font color="blue">treatment_1</font> <font color="blue">with_1</font> <font color="blue">methotrexate_1</font> <font color="blue">or_1</font> <font color="blue">placebo_1</font> <font color="blue">._1</font> 
<br>
<br> We investigated <font color="blue">whether_1</font> <font color="blue">5_1</font> <font color="blue">to_1</font> <font color="blue">20_1</font> <font color="blue">mg_1</font> <font color="blue">per_1</font> <font color="blue">week_1</font> <font color="blue">oral_1</font> <font color="blue">methotrexate_1</font> <font color="blue">could_1</font> <font color="blue">slow_1</font> <font color="blue">down_1</font> <font color="blue">disease_2</font> <font color="blue">progression_2</font> <font color="blue">in_1</font> <font color="blue">44_1</font> <font color="blue">patients_1</font> <font color="blue">with_1</font> <font color="blue">inclusion_1</font> <font color="blue">body_1</font> <font color="blue">myositis_1</font> in a randomized double - blind placebo - controlled study over 48 weeks . <font color="blue">Mean_4</font> <font color="blue">change_4</font> <font color="blue">of_4</font> <font color="blue">quantitative_4</font> <font color="blue">muscle_4</font> <font color="blue">strength_4</font> <font color="blue">testing_4</font> <font color="blue">sum_4</font> <font color="blue">scores_4</font> <font color="blue">was_1</font> <font color="blue">the_1</font> <font color="blue">primary_1</font> <font color="blue">study_1</font> <font color="blue">outcome_1</font> <font color="blue">measure_1</font> <font color="blue">._1</font> <font color="blue">Quantitative_5</font> <font color="blue">muscle_6</font> <font color="blue">strength_6</font> <font color="blue">testing_6</font> <font color="blue">sum_6</font> <font color="blue">scores_6</font> <font color="blue">declined_2</font> <font color="blue">in_1</font> <font color="blue">both_1</font> <font color="blue">treatment_1</font> <font color="blue">groups_1</font> <font color="blue">,_1</font> <font color="blue">-0.2%_1</font> <font color="blue">for_1</font> <font color="blue">methotrexate_1</font> <font color="blue">and_1</font> <font color="blue">-3.4%_1</font> <font color="blue">for_1</font> <font color="blue">placebo_1</font> <font color="blue">(_1</font> <font color="blue">95%_1</font> <font color="blue">confidence_1</font> <font color="blue">interval_1</font> <font color="blue">=_1</font> <font color="blue">-2.5%_1</font> <font color="blue">to_1</font> <font color="blue">+_1</font> <font color="blue">9.1%_1</font> <font color="blue">for_1</font> <font color="blue">difference_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> <font color="blue">There_1</font> <font color="blue">were_1</font> <font color="blue">also_1</font> <font color="blue">no_2</font> <font color="blue">differences_2</font> <font color="blue">in_1</font> <font color="blue">manual_5</font> <font color="blue">muscle_5</font> <font color="blue">testing_5</font> <font color="blue">sum_5</font> <font color="blue">scores_5</font> <font color="blue">,_5</font> <font color="blue">activity_5</font> <font color="blue">scale_5</font> <font color="blue">scores_5</font> <font color="blue">and_4</font> <font color="blue">patients_5</font> <font color="blue">'_5</font> <font color="blue">own_5</font> <font color="blue">assessments_5</font> <font color="blue">after_1</font> <font color="blue">48_1</font> <font color="blue">weeks_1</font> <font color="blue">of_1</font> <font color="blue">treatment_1</font> <font color="blue">._1</font> <font color="blue">Serum_5</font> <font color="blue">creatine_5</font> <font color="blue">kinase_5</font> <font color="blue">activity_5</font> <font color="blue">decreased_2</font> <font color="blue">significantly_2</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">methotrexate_1</font> <font color="blue">group_1</font> <font color="blue">._1</font> We conclude that <font color="blue">oral_1</font> <font color="blue">methotrexate_1</font> <font color="blue">did_1</font> <font color="blue">not_1</font> <font color="blue">slow_1</font> <font color="blue">down_1</font> <font color="blue">progression_3</font> <font color="blue">of_3</font> <font color="blue">muscle_4</font> <font color="blue">weakness_4</font> <font color="blue">but_1</font> <font color="blue">decreased_1</font> <font color="blue">serum_4</font> <font color="blue">creatine_4</font> <font color="blue">kinase_4</font> <font color="blue">activity_4</font> <font color="blue">._4</font>